{"id":"W2886065680","doi":"10.1016/j.euo.2018.07.003","title":"Comparative Effectiveness of Non-cisplatin First-line Therapies for Metastatic Urothelial Carcinoma: Phase 2 IMvigor210 Study Versus US Patients Treated in the Veterans Health Administration","year":2018,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"F. Hoffmann-La Roche","keywords":"Atezolizumab; Carboplatin; Medicine; Gemcitabine; Oncology; Internal medicine; Cisplatin; Hazard ratio; Chemotherapy; Metastatic Urothelial Carcinoma; Cancer; Bladder cancer; Urothelial carcinoma; Nivolumab; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001549331,0.0008417239,0.001934853,0.0004086467,0.0002670929,0.0008715367,0.000950667,0.001087037,0.003549071],"category_scores_gemma":[0.00153094,0.0003682614,0.00213432,0.0005380764,0.0006721574,0.0009648256,0.0004532386,0.002126132,0.0003921365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00109659,"about_ca_system_score_gemma":0.00104148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001543886,"about_ca_topic_score_gemma":0.003537052,"domain_scores_codex":[0.9991341,0.0006035987,0.00002788006,0.00009150154,0.00003754822,0.0001054385],"domain_scores_gemma":[0.9990495,0.0002685692,0.0002213444,0.0000765818,0.00003850352,0.0003454364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9447488,0.01207224,0.007482702,0.0002458499,0.001490655,0.0000409017,0.00008862109,0.001051199,0.003963861,0.000116164,0.0006886958,0.0280103],"study_design_scores_gemma":[0.4339846,0.5085406,0.04955267,0.00005326593,0.00259114,0.0001324576,0.0001777577,0.001378005,0.001858182,0.0001586366,0.001536849,0.0000359241],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972363,0.001261632,0.00006902628,0.0001804202,0.00004599234,0.0001631562,0.0004423361,0.00001428567,0.0005867808],"genre_scores_gemma":[0.9966815,0.0009249593,0.0002037481,0.0002283154,0.00009413208,0.0001696282,0.000925724,0.00001108465,0.0007609089],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003549071,"threshold_uncertainty_score":0.01187283,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07254437410222264,"score_gpt":0.412456320571144,"score_spread":0.3399119464689213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}